| (Values in U.S. Thousands) | Mar, 2018 | Dec, 2017 | Sep, 2017 | Jun, 2017 | Mar, 2017 |
| Sales | 1,090 | 1,230 | 1,210 | 1,020 | 1,500 |
| Sales Growth | -11.38% | +1.65% | +18.63% | -32.00% | +30.43% |
| Net Income | -1,300 | -530 | -1,280 | 530 | -1,040 |
| Net Income Growth | -145.28% | +58.59% | -341.51% | +150.96% | +50.71% |
Visualant Inc (VSUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Visualant is a public company based in Seattle, Washington, whose shares trade under the stock symbol VSUL. Visualant's technology directs structured light at a material (solid surface, liquid or gas) to capture a unique ChromaID signature. When matched against a database or model, a ChromaID signature can be used to identify, detect, or diagnose properties invisible to the human eye. ChromaID scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab-based tests. Visualant has a Joint Development Agreement through December 31, 2013 with Sumitomo Precision Products Co., Ltd., which focuses on the commercialization of the ChromaID technology and an exclusive license in identified Asian territories.